Trademark Search  /  ARGENX

ARGENX

● Live · Pending

U.S. federal trademark · Serial No. 98957449 · Reg. No. 1510907

Mark
ARGENX
Status
Pending
Serial Number
98957449
Registration No.
1510907
Filing Date
September 16, 2024
Registration Date
November 30, 2024
Class(es)
Class 005, Class 035, Class 042, Class 044

Owners

Argenx B.V.
99 · Zwijnaarde, BE
Argenx B.V.
99 · Zwijnaarde, BE

Goods & Services

Wholesale and retail store services for therapeutic pharmaceutical preparations in the field of immunology and auto-immune diseases and antibodies or fragments or derivatives of antibodies with therapeutic properties; business administrative services in relation to patient information in the field of immunology, diseases of the immune system and antibody therapeutics; business administration of patient reimbursement programs

Providing information to patients in the field of auto-immune, antibody-mediated, neuromuscular, hematological, inflammatory, respiratory, kidney, skin, and transplantation-related diseases and disorders, cancer and diseases of the immune system and the treatment thereof; medical consultancy and information services relating to therapeutic biopharmaceutical products; Provision of medical information on therapeutic pharmaceutical, medical, and healthcare products to customers or patients through an online computer network

Research and development in the field of immunology, antibody engineering and autoimmune diseases for therapeutic purposes; therapeutic drug research and development in the field of immunology, antibody technology and autoimmune diseases; scientific and technological services, namely, research relating to immunity, autoimmune diseases and antibody engineering for therapeutic purposes; providing medical and scientific research information in the field of therapeutic pharmaceuticals, clinical trials, research and development

Pharmaceuticals and medical preparations for therapeutic purposes in the field of immunology and autoimmune diseases; pharmaceutical preparations for the prevention or treatment of autoimmune, antibody-mediated, neuromuscular, hematological, inflammatory, respiratory, kidney, skin, and transplantation-related diseases and disorders, cancer and diseases of the immune system; compositions of antibodies or fragments of antibodies or derivatives of antibodies with therapeutic properties; antibodies or fragments of antibodies or derivatives of antibodies for the prevention or treatment of autoimmune, antibody-mediated, neuromuscular, hematological, inflammatory, respiratory, kidney, skin, transplantation-related diseases and disorders, cancer and diseases of the immune system

Thinking of using a similar name?
Search 14 million+ trademarks free and see if your brand conflicts with "ARGENX" or anything like it, before you file.
Run a free trademark search →

Source: USPTO federal trademark records. Informational only, not legal advice. Status and details may lag the live USPTO database.